Stanford Prof Urges Cost Analyses On Personalized Medicine
This article was originally published in The Gray Sheet
Personalized medicine proponents will likely need to produce persuasive cost-effectiveness analyses to spur adoption in light of rising healthcare costs
You may also be interested in...
Medical technology advances from 1980-2000 helped prevent 470,000 deaths, 2.3 mil. disabilities and 206 mil. days spent in the hospital, according to a study released Jan. 28
A combined final opinion on the European Chemicals Agency’s proposed microplastic restriction is expected from ECHA committees by year-end, at which point the European Commission will consider whether and when microplastic must be removed from all leave-on cosmetic products marketed in the EU.
Butterfly Network’s CEO Laurent Faracci outlines the company’s growth strategy and plans for their “ultrasound-on-a-chip” technology after its merger with blank check company Longview Acquisition Corp. See what the company’s CEO said about it here.